Free Trial
OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

Acura Pharmaceuticals logo
$0.0005 0.00 (0.00%)
As of 07/25/2025

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
$0.00
$0.02
52-Week Range
$0.00
$0.75
Volume
N/A
Average Volume
1,891 shs
Market Capitalization
$33.25 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACUR Stock News Headlines

Acura Pharma Stock Price History - Investing.com
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Acura Pharmaceuticals, Inc. (ACUR) - Yahoo Finance
See More Headlines

ACUR Stock Analysis - Frequently Asked Questions

Acura Pharmaceuticals' stock was trading at $0.0002 at the beginning of 2025. Since then, ACUR shares have increased by 150.0% and is now trading at $0.0005.

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) issued its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.

Acura Pharmaceuticals subsidiaries include Acura Pharmaceutical Technologies Inc..

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Ekso Bionics (EKSO), VIVUS (VVUS), Corbus Pharmaceuticals (CRBP), Fulcrum Therapeutics (FULC) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
2/28/2020
Today
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ACUR
Previous Symbol
NASDAQ:ACUR
CIK
786947
Employees
10
Year Founded
1935

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
66,500,000
Free Float
53,066,000
Market Cap
$33.25 thousand
Optionable
Not Optionable
Beta
-2.43

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:ACUR) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners